# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104565
Filing Date
2025-08-07
Accepted
2025-08-07 07:30:23
Documents
69
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rapp-20250630.htm iXBRL | 10-Q | 3029165
2 | EX-10.1 | rapp-ex10_1.htm | EX-10.1 | 206744
3 | EX-31.1 | rapp-ex31_1.htm | EX-31.1 | 17520
4 | EX-31.2 | rapp-ex31_2.htm | EX-31.2 | 16621
5 | EX-32.1 | rapp-ex32_1.htm | EX-32.1 | 15960
| Complete submission text file | 0000950170-25-104565.txt |  | 10225835

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rapp-20250630.xsd | EX-101.SCH | 1305599
72 | EXTRACTED XBRL INSTANCE DOCUMENT | rapp-20250630_htm.xml | XML | 1668005

Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42121 | Film No.: 251191599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)